Evaluation of the efficacy and safety of salvia officinalis in controlling hot flashes in prostate cancer patients treated with androgen deprivation

Phytotherapy Research

Volumn 26, Issue 2, 2012, Pages 208-213

  Vandecasteele, Katrien ^a   Ost, Piet ^a   Oosterlinck, Willem ^a   Fonteyne, Valérie ^a   De Neve, Wilfried ^a   De Meerleer, Gert ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

androgen deprivation; hot flashes; prostate cancer; Salvia officinalis

Indexed keywords

ANTIANDROGEN; CHOLESTEROL; FOLLITROPIN; HEMOGLOBIN; LUTEINIZING HORMONE; SALVIA OFFICINALIS EXTRACT; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; AGED; ANDROGEN DEPRIVATION THERAPY; ARTICLE; CANCER PATIENT; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; EVENING DOSAGE; FOLLITROPIN BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HOT FLUSH; HUMAN; LUTEINIZING HORMONE BLOOD LEVEL; MALE; MORNING DOSAGE; MOYAD SCORE; OUTCOME ASSESSMENT; PILOT STUDY; PROSPECTIVE STUDY; PROSTATE CANCER; PROTEIN BLOOD LEVEL; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; SIDE EFFECT; TESTOSTERONE BLOOD LEVEL;

AGED; ANDROGEN ANTAGONISTS; HOT FLASHES; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; PLANT EXTRACTS; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; QUALITY OF LIFE; SALVIA OFFICINALIS;

SALVIA OFFICINALIS;

EID: 84856277103     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.3528     Document Type: Article

References (29)

1. Akhondzadeh S, Noroozian M, Mohammadi M, Ohadinia S, Jamshidi AH, Khani M,. 2003. Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomized and placebo-controlled trial. J Clin Pharm Ther 28: 53-59. (Pubitemid 36313176)
2. Carpenter JS,. 2001. The hot flash related daily interference scale: a tool for assessing the impact of hot flashes on quality of life following breast cancer. J Pain Symptom Manage 22: 979-989. (Pubitemid 33152683)
3. Charig CR, Rundle JS,. 1989. Flushing. Long-term side effect of orchiectomy in treatment of prostatic carcinoma. Urology 33: 175-178. (Pubitemid 19089637)
4. De Leo V, Lanzetta D, Cazzavacca R, Morgante G,. 1998. Treatment of neurovegetative menopausal symptoms with a phytotherapeutic agent. Minerva Ginecol 50: 207-211. (Pubitemid 28331864)
5. Flaig TW, Glode LM,. 2008. Management of the side effects of androgen deprivation therapy in men with prostate cancer. Exp Opin Pharmacother 9: 2829-2841.
6. Gomella LG,. 2007. Contemporary use of hormonal therapy in prostate cancer: managing complications and addressing quality-of-life issues. BJU Int 99: 25-29. (Pubitemid 44952826)
7. Higano CS,. 2003. Side effects of androgen deprivation therapy: monitoring and minimizing toxicity. Urology 61: 32-38. (Pubitemid 36349540)
8. Holzbeierlein JM, McLaughlin MD, Thrasher JB,. 2004. Complications of androgen deprivation therapy for prostate cancer. Curr Opin Urol 14: 177-183. (Pubitemid 38582317)
9. Karling P, Hammar M, Varenhorst E,. 1994. Prevalence and duration of hot flushes after surgical or medical castration in men with prostatic carcinoma. J Urol 152: 1170-1173. (Pubitemid 24283460)
10. Kattan MW,. 2006. Measuring hot flashes in men treated with hormone ablation therapy: an unmet need. Urol Nurs 26: 13-18.
11. Kouriefs C, Georgiou M, Ravi R,. 2002. Hot flushes and prostate cancer: pathogenesis and treatment. BJU Int 89: 379-383. (Pubitemid 34304362)
12. Langenstroer P, Kramer B, Cutting B, et al., 2005. Parenteral medroxyprogesterone for the management of luteinizing hormone releasing hormone induced hot flashes in men with advanced prostate cancer. J Urol 174: 642-645. (Pubitemid 40981622)
13. Loprinzi CL, Barton DL, Carpenter LA, et al., 2004. Pilot evaluation of paroxetine for treating hot flashes in men. Mayo Clin Proc 79: 1247-1251. (Pubitemid 39299067)
14. Loprinzi CL, Dueck AC, Khoyratty BS, et al., 2009. A phase III randomized, double-blind, placebo-controlled trial of gabapentin in the management of hot flashes in men (N00CB). Ann Oncol 20: 542-549.
15. Loprinzi CL, Michalak JC, Quella SK, et al., 1994. Megestrol acetate for the prevention of hot flashes. N Engl J Med 331: 347-352. (Pubitemid 24233853)
16. Mohile SG, Mustian K, Bylow K, Hall W, Dale W,. 2009. Management of complications of androgen deprivation therapy in the older man. Crit Rev Oncol Hematol 70: 235-255.
17. Mohsen I, Hossein H,. 2006. The pharmacological effects of Salvia species on the central nervous system. Phytother Res 20: 427-437.
18. Moyad MA,. 2002. Complementary/alternative therapies for reducing hot flashes in prostate cancer patients: reevaluating the existing indirect data from studies of breast cancer and postmenopausal women. Urology 59: 20-33. (Pubitemid 34286428)
19. Moyad MA,. 2005. Promoting general health during androgen deprivation therapy (ADT): A rapid 10-step review for your patients. Urol Oncol Semin Orig Invest 23: 56-64. (Pubitemid 40692268)
20. Nelson HD, Vesco KK, Haney E, et al., 2006. Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis. JAMA 295: 2057-2071. (Pubitemid 44794007)
21. Nishiyama T, Kanazawa S, Watanabe R, Terunuma M, Takahashi K,. 2004. Influence of hot flashes on quality of life in patients with prostate cancer treated with androgen deprivation therapy. Int J Urol 11: 735-741. (Pubitemid 39387520)
22. Pandya KJ, Morrow GR, Roscoe JA, et al., 2005. Gabapentin for hot flashes in 420 women with breast cancer: a randomised double-blind placebo-controlled trial. Lancet 366: 818-824. (Pubitemid 41557381)
23. Quella SK, Loprinzi CL, Sloan J, et al., 1999. Pilot evaluation of venlafaxine for the treatment of hot flashes in men undergoing androgen ablation therapy for prostate cancer. J Urol 162: 98-102. (Pubitemid 29420889)
24. Schow DA, Renfer LG, Rozanski TA, Thompson IM,. 1998. Prevalence of hot flushes during and after neoadjuvant hormonal therapy for localized prostate cancer. South Med J 91: 855-857.
25. Sculpher M, Bryan S, Fry P, de Winter P, Payne H, Emberton M,. 2004. Patients' preferences for the management of non-metastatic prostate cancer: discrete choice experiment. Br Med J 328: 382.
26. Sharifi N, Gulley JL, Dahut WL,. 2005. Androgen deprivation therapy for prostate cancer. JAMA 294: 238-244. (Pubitemid 41043794)
27. Sloan JA, Loprinzi CL, Novotny PJ, Barton DL, Lavasseur BI, Windschitl H,. 2001. Methodologic lessons learned from hot flash studies. J Clin Oncol 19: 4280-4290. (Pubitemid 33096775)
28. Stearns V, Slack R, Greep N, et al., 2005. Paroxetine is an effective treatment for hot flashes: results from a prospective randomized clinical trial. J Clin Oncol 23: 6919-6930.
29. Thompson CA, Shanafelt TD, Loprinzi CL,. 2003. Andropause: symptom management for prostate cancer patients treated with hormonal ablation. Oncologist 8: 474-487. (Pubitemid 37238876)